Professor Klaus Dugi

Published 26, August 2013 at 92 × 88 in Boehringer Ingelheim to unveil new data on the novel oral anticoagulant (NOAC) Pradaxa® (dabigatran etexilate) during the ESC Congress 2013 in Amsterdam

Professor Klaus Dugi, Senior Vice President Medicine at Boehringer Ingelheim

Professor Klaus Dugi, Senior Vice President Medicine at Boehringer Ingelheim

Bookmark the permalink.

Comments are closed.